High-performance liquid chromatographic quantitation of total and lactone 20(S)camptothecin in patients receiving oral 20(S)camptothecin

被引:21
作者
Ahmed, F
Vyas, V
Saleem, A
Li, XG
Zamek, R
Cornfield, A
Haluska, P
Ibrahim, N
Rubin, EH
Gupta, E
机构
[1] Univ Med & Dent New Jersey, Canc Inst New Jersey, New Brunswick, NJ 08901 USA
[2] Rutgers State Univ, Piscataway, NJ 08854 USA
来源
JOURNAL OF CHROMATOGRAPHY B | 1998年 / 707卷 / 1-2期
关键词
lactone 20(S)camptothecin; 20(S)camptothecin;
D O I
10.1016/S0378-4347(97)00615-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We have developed a sensitive high-performance liquid chromatography (HPLC) assay to quantitate total and lactone forms of 20(S)camptothecin (CPT) in human plasma. Lactone and total CPT were extracted using solid-phase extraction and liquid-liquid extraction, respectively. The extracted lactone samples could be stored without immediate HPLC analysis. The two forms of CPT were quantitated by reversed-phase HPLC with fluorescence detection. The extraction efficiencies were about 100% and 92% for the total and lactone forms, respectively. The lower limit of quantitation was 5.74 nM for the two forms. The method was reproducible with a mean interday and intraday variability of 6% for total CPT and 4% and 6%, respectively, for lactone CPT. The assay could effectively quantitate lactone and total CPT in patients receiving single dose and multiple doses of oral CPT. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 19 条
[1]   THE IMPORTANT ROLE OF ALBUMIN IN DETERMINING THE RELATIVE HUMAN BLOOD STABILITIES OF THE CAMPTOTHECIN ANTICANCER DRUGS [J].
BURKE, TG ;
MUNSHI, CB ;
MI, ZH ;
JIANG, Y .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) :518-519
[2]   THE S-PHASE CYTOTOXICITY OF CAMPTOTHECIN [J].
DELBINO, G ;
LASSOTA, P ;
DARZYNKIEWICZ, Z .
EXPERIMENTAL CELL RESEARCH, 1991, 193 (01) :27-35
[3]  
FASSBERG J, 1992, J PHARM SCI, V81, P876
[4]  
GIBALDI M, 1991, BIOPHARMACEUTICS CLI
[5]  
Gupta E., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P75
[6]   MODIFICATION OF THE HYDROXY LACTONE RING OF CAMPTOTHECIN - INHIBITION OF MAMMALIAN TOPOISOMERASE-I AND BIOLOGICAL-ACTIVITY [J].
HERTZBERG, RP ;
CARANFA, MJ ;
HOLDEN, KG ;
JAKAS, DR ;
GALLAGHER, G ;
MATTERN, MR ;
MONG, SM ;
BARTUS, JO ;
JOHNSON, RK ;
KINGSBURY, WD .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (03) :715-720
[7]   ON THE MECHANISM OF TOPOISOMERASE-I INHIBITION BY CAMPTOTHECIN - EVIDENCE FOR BINDING TO AN ENZYME DNA COMPLEX [J].
HERTZBERG, RP ;
CARANFA, MJ ;
HECHT, SM .
BIOCHEMISTRY, 1989, 28 (11) :4629-4638
[8]  
HSIANG YH, 1988, CANCER RES, V48, P1722
[9]  
HSIANG YH, 1985, J BIOL CHEM, V260, P4873
[10]  
HSIANG YH, 1989, CANCER RES, V49, P4385